Stocks
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -7.59 | -1.67 | -4.00 | -5.34 | -2.04 | -3.86 | ||
| Changes by years, y/y, % | -67% | -78% | +139% | +34% | -62% | -38.6% | |||
Iovance Biotherapeutics. EV/EBITDA
Iovance Biotherapeutics. EV/EBITDA, changes, %
Iovance Biotherapeutics (IOVA) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | -5.66 | -2.19 | -0.91 | -1.47 | -2.39 | -3.86 | |
| Changes by years, y/y, % | +29% | -74% | -81% | -77% | -58% | |||
| Changes by quarters, q/q, % | -13% | -61% | -59% | +62% | +62% | |||
